Case Studies

29. July 2026

Case Study I Studying host-pathogen interactions during Candida albicans infections with organ-on-chip

We had the opportunity to speak to Hristina Koceva, PhD student at the University Hospital Jena. Hristina is studying immunometabolic modulation during Influenza A infection in a human iPSC-based alveolus-on-chip model.  

27. July 2026

Case Study I Investigating infection dynamics of invasive mucormycosis in lung-on-chip

We had the opportunity to speak to Hristina Koceva, PhD student at the University Hospital Jena. Hristina is studying immunometabolic modulation during Influenza A infection in a human iPSC-based alveolus-on-chip model.  

27. July 2026

Case Study I Modeling Bilophila infection in a gut-on-chip model

We had the opportunity to speak to Hristina Koceva, PhD student at the University Hospital Jena. Hristina is studying immunometabolic modulation during Influenza A infection in a human iPSC-based alveolus-on-chip model.  

27. July 2026

Case Study I Studying a drug delivery system for post-surgical treatment of glaucoma patients

We had the opportunity to speak to Hristina Koceva, PhD student at the University Hospital Jena. Hristina is studying immunometabolic modulation during Influenza A infection in a human iPSC-based alveolus-on-chip model.  

22. July 2026

Case Study I Alveolus-on-chip model to study immunometabolic modulation during Influenza A virus infection

We had the opportunity to speak to Hristina Koceva, PhD student at the University Hospital Jena. Hristina is studying immunometabolic modulation during Influenza A infection in a human iPSC-based alveolus-on-chip model.  

20. July 2026

Case Study I Predicting drug safety during pregnancy using organ-on-chip and digital twinning

We had the opportunity to speak to Christian Maass, Lead of MPSlabs, a business unit of ESQlabs GmbH in Germany. Chris talks about our joint project on predicting drug safety during pregnancy by combining in vitro data from a gut-liver-placenta model with digital twinning.

20. July 2026

Case Study I Human enteroid-derived gut-on-chip model to study Hepatitis E Virus replication

We had the opportunity to Dr. Nanci dos Santos Ferreira, PostDoc at the Porto Lab at KU Leuven in Belgium. She is working on the development of an human intestinal enteroid-derived gut-on-chip model to study the replication and dissemination of Hepatitis E Virus (HEV) in the gut-liver-axis.

9. April 2026

Case Study I Intestine-on-chip to study infection and inflammation dynamics

We had the opportunity to speak to Dr. Manasa Nandimandalam from the Hannover Medical School. She developed an advanced in vitro model on-chip to simulate intestinal environments for comprehensive studies of infection and inflammation dynamics.

9. April 2026

Case Study I Intestinal adenocarcinoma-on-chip model

We had the opportunity to speak to Valentin Wegner from the University Hospital Jena in Germany. He works on the modulation of CAR T-cell efficacy by short-chain fatty acids in a ROR1-positive intestinal adenocarcinoma-on-chip model.

9. April 2026

Case Study I Microphysiological approach to study dopaminergic injury and inflammation interplay in Parkinson’s disease

We had the opportunity to speak to Inês Silva from the NOVA Institute for Medical Systems Biology in Portugal. She has developed a microphysiological approach to study dopaminergic injury and inflammation interplay in Parkinson’s disease.

9. April 2026

Case Study I Microglia crosstalk MPS model of the blood-brain barrier

We had the opportunity to speak Daniela Marques from the NOVA Institute for Medical Systems Biology in Portugal. She has developed a microglia crosstalk MPS model of the blood-brain barrier to disclose polyphenol metabolites potential.

9. April 2026

Case Study I Vibrio cholerae in a 3D-intestine-on-chip infection model

We had the opportunity to speak Adrian Feile from the University Hospital Jena in Germany. He has shown that DPO (3,5-dimethylpyrazin-2-ol)-dependent quorum sensing modulates biofilm behavior of Vibrio cholerae in a 3D-intestine-on-chip infection model.

9. April 2026

Case Study I Intestine-on-chip that enables Clostridioides difficile infection in a hypoxic microenvironment

We had the opportunity to speak to Maria Warschinke from the University Hospital Jena in Germany. She is working on an immunocompetent intestine-on-chip that enables Clostridioides difficile infection in a hypoxic microenvironment.

8. April 2026

Case Study I Stem cell-derived gut-on-chip model to elucidate human norovirus infections

We had the opportunity to speak to Dr. Nicole Engert from University Hospital Jena in Germany. She is working on a stem cell-derived gut-on-chip technology to elucidate human norovirus infections.